科特迪瓦青少年HIV感染女孩HPV疫苗接种率及影响因素调查
该研究在科特迪瓦15家HIV儿科机构对659名青少年HIV感染女孩(中位年龄15岁)进行全国代表性横断面调查,发现仅14.7%至少接种一剂HPV疫苗。认知不足是主要障碍(85.4%),识别HPV为宫颈癌风险因素、曾参加性教育焦点小组及在阿比让以外接受护理与接种率较高独立相关。
要点
- 青少年HIV感染女孩HPV疫苗接种率低(14.7%),需紧急干预。
- 缺乏疫苗信息是主要障碍(85.4%),家长拒绝和担心不良事件次之。
- 识别HPV为宫颈癌风险因素者接种可能性更高(aOR=4.02)。
核心结论
- 科特迪瓦青少年HIV感染女孩HPV疫苗接种率低,需以人为中心的干预措施结合学校与机构途径以提高接种率。
研究设计与样本
- 2024年7月至2025年2月在科特迪瓦15家HIV儿科机构开展的全国代表性横断面调查,采用混合方法,纳入659名青少年HIV感染女孩(中位年龄15岁,IQR 13-17)。
主要发现
- 97名参与者(14.7%)至少接种一剂HPV疫苗。
- 报告障碍包括缺乏疫苗信息(85.4%)、家长拒绝(8.9%)和担心不良事件(5.7%)。
- 识别HPV为宫颈癌风险因素(aOR=4.02,95%CI 1.87-8.62)、曾参加性教育焦点小组(aOR=1.79,95%CI 1.07-2.99)和在阿比让以外接受护理(aOR=3.07,95%CI 1.88-5.01)与接种率独立相关。
- 深入访谈强调缺乏信息、污名化、家长影响和医务人员未提议疫苗是障碍。
临床怎么用
- 应针对青少年HIV感染女孩加强HPV疫苗信息宣传,并鼓励医务人员主动提议接种。
- 可结合学校与HIV护理机构提供接种服务,并关注家长态度和污名化问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human papillomavirus (HPV) vaccination programs are scaling-up in low-and-middle-income countries, targeting girls aged 9 to 14, usually through a school-based approach. However, specific data on adolescent girls living with HIV (AGLHIV) are lacking. We estimated the HPV vaccine uptake and its determinants among AGLHIV in Côte d'Ivoire. METHODS: A nationally representative survey was conducted within HIV pediatric facilities from July 2024 to February 2025 through a mixed-method approach. Participating facilities were selected through a hybrid sampling combining the inclusion of the largest pediatric HIV facilities and a random sample of integrated HIV facilities. Vaccine uptake was documented from immunization records, and questionnaires to AGLHIV. A logistic regression analysis was used to assess factors associated with HPV vaccine uptake. In-depth interviews were conducted with AGLHIV, parents/guardians, and healthcare workers (HCW) to assess barriers to HPV vaccine uptake. RESULTS: Overall, 659 AGLHIV (median age 15 years [IQR: 13-17]) were included across 15 HIV facilities. Among participants, 97 (14.7%) received at least one dose of HPV vaccine. Reported barriers to vaccination included: lack of information about the vaccine (85.4%), parents' refusal (8.9%) and fear of adverse events (5.7%). Identifying HPV as a risk factor for cervical cancer (adjusted Odds Ratio (aOR) = 4.02 [95% CI: 1.87-8.62], having ever attended a focus group on sexual education (aOR = 1.79 [95% CI: 1.07-2.99] and receiving care outside of Abidjan (aOR = 3.07 [95% CI: 1.88-5.01]) were independently associated with vaccine uptake. In-depth interviews highlighted a lack of information, stigma, parental influence, and a lack of vaccine proposition by HCW as barriers to HPV vaccination. CONCLUSION: The HPV vaccine uptake was low among AGLHIV in Côte d'Ivoire. Person-centered interventions combining school- and facility-based approaches, with dedicate monitoring tools, are urgently needed to achieve the WHO 90% HPV vaccination coverage among AGLHIV.
引用
- Boni S, Quessette M, Nedelec E, et al. Human papillomavirus vaccine uptake among adolescent girls living with HIV in Côte d'Ivoire: A national cross-sectional survey. Vaccine. 2026. PMID: 41819638. doi:10.1016/j.vaccine.2026.128434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。